Nifty
Sensex
:
:
23123.00
73524.26
-243.70 (-1.04%)
-719.08 (-0.97%)

Pharmaceuticals & Drugs

Rating :
66/99

BSE: 540679 | NSE: HALEOSLABS

1356.70
08-Jun-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1340
  •  1375
  •  1340
  •  1384.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2519
  •  3422586.7
  •  1774
  •  1067

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 410.17
  • 23.69
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 516.65
  • 0.11%
  • 1.92

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.11%
  • 3.02%
  • 24.33%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 0.54%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 5.35
  • 2.99

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 8.32
  • 9.36

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 8.20
  • 20.58

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 17.44
  • 21.31

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 1.54
  • 1.62

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.82
  • 9.58

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
75.14
89.11
-15.68%
94.78
84.60
12.03%
81.37
78.46
3.71%
82.50
92.55
-10.86%
Expenses
70.98
81.69
-13.11%
80.73
71.85
12.36%
67.80
69.90
-3.00%
70.79
76.26
-7.17%
EBITDA
4.16
7.42
-43.94%
14.05
12.75
10.20%
13.57
8.56
58.53%
11.71
16.28
-28.07%
EBIDTM
5.54%
8.33%
14.82%
15.08%
16.68%
10.91%
14.20%
17.60%
Other Income
2.01
2.34
-14.10%
0.18
0.06
200.00%
0.42
2.04
-79.41%
1.00
0.44
127.27%
Interest
1.42
2.03
-30.05%
1.54
2.14
-28.04%
1.61
2.14
-24.77%
1.86
2.41
-22.82%
Depreciation
3.85
3.80
1.32%
3.91
3.76
3.99%
3.89
3.76
3.46%
3.82
3.68
3.80%
PBT
0.91
3.93
-76.84%
8.78
6.92
26.88%
8.49
4.70
80.64%
7.02
10.64
-34.02%
Tax
0.56
0.45
24.44%
2.13
2.06
3.40%
2.07
1.40
47.86%
2.64
3.54
-25.42%
PAT
0.34
3.48
-90.23%
6.65
4.85
37.11%
6.43
3.30
94.85%
4.38
7.10
-38.31%
PATM
0.46%
3.91%
7.01%
5.74%
7.90%
4.20%
5.31%
7.67%
EPS
1.44
9.83
-85.35%
21.89
18.08
21.07%
20.19
15.46
30.60%
13.75
22.99
-40.19%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
333.79
344.72
305.96
315.56
350.07
265.59
260.78
377.85
Net Sales Growth
-3.17%
12.67%
-3.04%
-9.86%
31.81%
1.84%
-30.98%
 
Cost Of Goods Sold
140.66
154.06
151.16
171.41
194.68
137.04
157.88
255.87
Gross Profit
193.13
190.66
154.80
144.16
155.39
128.55
102.90
121.98
GP Margin
57.86%
55.31%
50.59%
45.68%
44.39%
48.40%
39.46%
32.28%
Total Expenditure
290.30
299.63
274.74
286.74
315.54
235.35
235.38
343.09
Power & Fuel Cost
-
32.53
30.45
29.28
30.02
21.56
20.48
25.93
% Of Sales
-
9.44%
9.95%
9.28%
8.58%
8.12%
7.85%
6.86%
Employee Cost
-
59.54
52.26
43.43
39.90
30.66
26.56
23.11
% Of Sales
-
17.27%
17.08%
13.76%
11.40%
11.54%
10.18%
6.12%
Manufacturing Exp.
-
34.16
28.10
28.22
35.77
29.16
20.26
24.94
% Of Sales
-
9.91%
9.18%
8.94%
10.22%
10.98%
7.77%
6.60%
General & Admin Exp.
-
7.56
7.05
8.32
7.47
6.95
5.69
5.84
% Of Sales
-
2.19%
2.30%
2.64%
2.13%
2.62%
2.18%
1.55%
Selling & Distn. Exp.
-
6.32
5.23
5.25
6.97
6.75
4.30
6.74
% Of Sales
-
1.83%
1.71%
1.66%
1.99%
2.54%
1.65%
1.78%
Miscellaneous Exp.
-
5.46
0.48
0.84
0.72
3.23
0.21
0.66
% Of Sales
-
1.58%
0.16%
0.27%
0.21%
1.22%
0.08%
0.17%
EBITDA
43.49
45.09
31.22
28.82
34.53
30.24
25.40
34.76
EBITDA Margin
13.03%
13.08%
10.20%
9.13%
9.86%
11.39%
9.74%
9.20%
Other Income
3.61
4.86
3.83
3.07
1.74
1.78
2.28
2.51
Interest
6.43
8.77
10.26
6.87
6.23
4.60
5.15
5.51
Depreciation
15.47
15.00
14.94
10.79
10.01
7.86
7.86
6.38
PBT
25.20
26.19
9.85
14.24
20.04
19.57
14.67
25.39
Tax
7.40
7.46
3.52
5.22
7.43
6.01
4.48
7.54
Tax Rate
29.37%
28.48%
35.74%
31.46%
22.70%
30.71%
30.54%
29.70%
PAT
17.80
20.11
9.10
11.47
25.32
13.56
10.18
17.85
PAT before Minority Interest
17.31
18.73
6.33
11.38
25.30
13.56
10.18
17.85
Minority Interest
-0.49
1.38
2.77
0.09
0.02
0.00
0.00
0.00
PAT Margin
5.33%
5.83%
2.97%
3.63%
7.23%
5.11%
3.90%
4.72%
PAT Growth
-4.97%
120.99%
-20.66%
-54.70%
86.73%
33.20%
-42.97%
 
EPS
59.33
67.03
30.33
38.23
84.40
45.20
33.93
59.50

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
196.56
176.81
168.61
152.23
129.22
115.73
106.33
Share Capital
3.02
3.02
3.02
3.02
3.02
3.02
3.02
Total Reserves
193.54
173.79
165.59
149.21
126.19
112.71
103.31
Non-Current Liabilities
35.88
52.32
73.11
56.38
59.00
50.06
38.60
Secured Loans
18.27
33.15
51.34
35.38
34.19
31.76
21.83
Unsecured Loans
0.00
0.00
3.60
4.95
4.95
4.95
5.38
Long Term Provisions
5.13
4.74
4.10
3.51
3.04
2.70
2.33
Current Liabilities
151.07
148.81
137.06
143.06
118.76
90.10
131.56
Trade Payables
53.27
59.13
59.67
77.89
67.03
49.03
97.91
Other Current Liabilities
36.71
37.01
42.48
28.55
25.44
15.57
13.59
Short Term Borrowings
50.46
46.76
30.11
27.14
20.20
20.96
12.77
Short Term Provisions
10.62
5.91
4.80
9.48
6.09
4.54
7.30
Total Liabilities
399.00
394.76
398.38
364.37
306.98
255.89
276.49
Net Block
231.85
223.34
228.36
142.03
129.78
124.13
117.43
Gross Block
312.24
289.58
280.62
177.21
164.01
149.59
135.78
Accumulated Depreciation
80.39
66.24
52.26
35.18
34.24
25.47
18.34
Non Current Assets
239.42
235.25
235.77
200.73
176.01
145.61
127.63
Capital Work in Progress
0.40
6.00
0.85
51.18
38.31
15.76
3.29
Non Current Investment
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Long Term Loans & Adv.
7.13
5.87
6.53
7.48
7.88
5.68
4.90
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
1.05
Current Assets
159.57
159.52
162.62
163.64
130.97
110.28
148.86
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
67.40
81.21
86.23
84.81
61.63
64.30
81.17
Sundry Debtors
68.79
51.35
46.06
33.83
34.15
21.61
41.32
Cash & Bank
1.51
1.49
4.41
4.39
11.06
7.59
2.61
Other Current Assets
21.88
1.82
2.56
2.99
24.13
16.78
23.76
Short Term Loans & Adv.
21.24
23.65
23.35
37.62
23.30
11.13
13.05
Net Current Assets
8.51
10.71
25.55
20.57
12.21
20.18
17.30
Total Assets
398.99
394.77
398.39
364.37
306.98
255.89
276.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
34.05
24.31
14.70
-11.24
35.17
14.55
29.99
PBT
26.19
9.85
14.24
20.04
19.57
14.67
25.38
Adjustment
24.72
21.49
15.87
14.05
10.38
11.24
9.34
Changes in Working Capital
-8.36
-4.03
-12.15
-37.62
10.16
-8.30
1.94
Cash after chg. in Working capital
42.55
27.31
17.95
-3.53
40.10
17.61
36.67
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-8.50
-3.00
-3.26
-7.71
-4.93
-3.06
-6.67
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-15.00
-18.45
-31.29
-7.14
-26.23
-27.02
-44.01
Net Fixed Assets
-15.85
-13.12
-35.04
-14.94
-13.35
-15.06
Net Investments
0.00
0.00
0.01
2.57
0.00
0.00
Others
0.85
-5.33
3.74
5.23
-12.88
-11.96
Cash from Financing Activity
-19.12
-6.56
16.89
10.83
-2.55
12.45
15.37
Net Cash Inflow / Outflow
-0.07
-0.71
0.29
-7.55
6.39
-0.03
1.35
Opening Cash & Equivalents
0.57
1.28
0.99
8.54
2.15
2.17
0.82
Closing Cash & Equivalent
0.50
0.57
1.28
0.99
8.54
2.15
2.17

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
650.15
584.84
557.71
503.53
427.40
382.80
351.70
ROA
4.72%
1.60%
2.98%
7.54%
4.82%
3.83%
6.45%
ROE
10.03%
3.66%
7.09%
17.98%
11.07%
9.17%
16.78%
ROCE
12.60%
7.42%
9.45%
18.42%
12.96%
11.91%
20.14%
Fixed Asset Turnover
1.28
1.19
1.56
2.28
1.88
2.04
3.07
Receivable days
56.81
52.44
40.71
31.92
34.48
39.53
36.22
Inventory Days
70.27
90.14
87.15
68.75
77.87
91.38
71.14
Payable days
133.15
143.42
146.47
135.85
154.56
169.86
99.23
Cash Conversion Cycle
-6.07
-0.85
-18.60
-35.18
-42.21
-38.95
8.13
Total Debt/Equity
0.43
0.55
0.59
0.51
0.50
0.55
0.44
Interest Cover
3.99
1.96
3.42
6.26
5.26
3.85
5.61

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.